CERS down big after the company said it expects a supply shortage of a platelet additive solution to temporarily affect some U.S. blood centers and affect the company's 2017 revenue.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.